清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Burr-hole drainage with or without irrigation for chronic subdural haematoma (FINISH): a Finnish, nationwide, parallel-group, multicentre, randomised, controlled, non-inferiority trial

医学 硬膜下间隙 外科 随机对照试验 神经外科 改良兰金量表 排水 血肿 生态学 生物 心脏病学 缺血 缺血性中风
作者
Rahul Raj,Pihla Tommiska,Timo Koivisto,Ville Leinonen,Nils Danner,Jussi P. Posti,Dan Laukka,Teemu M. Luoto,Minna Rauhala,Sami Tetri,Tommi K. Korhonen,Jarno Satopää,Riku Kivisaari,Teemu Luostarinen,Christoph Schwartz,Tomasz Czuba,Simo Taimela,Kimmo Lönnrot,Teppo L. N. Järvinen,Abdirisak Ahmed
出处
期刊:The Lancet [Elsevier]
卷期号:403 (10446): 2798-2806 被引量:33
标识
DOI:10.1016/s0140-6736(24)00686-x
摘要

Background Chronic subdural haematoma is a common surgically treated intracranial emergency. Burr-hole drainage surgery, to evacuate chronic subdural haematoma, involves three elements: creation of a burr hole for access, irrigation of the subdural space, and insertion of a subdural drain. Although the subdural drain has been established as beneficial, the therapeutic effect of subdural irrigation has not been addressed. Methods The FINISH trial was an investigator-initiated, pragmatic, multicentre, nationwide, randomised, controlled, parallel-group, non-inferiority trial in five neurosurgical units in Finland that enrolled adults aged 18 years or older with a chronic subdural haematoma requiring burr-hole drainage. Patients were randomly assigned (1:1) by computer-generated block randomisation with block sizes of four, six, or eight, stratified by site, to burr-hole drainage either with or without subdural irrigation. All patients and staff were masked to treatment assignment apart from the neurosurgeon and operating room staff. A burr hole was drilled at the site of maximum haematoma thickness in both groups, and the subdural space was either irrigated or not irrigated before inserting a subdural drain, which remained in place for 48 h. Reoperations, functional outcome, mortality, and adverse events were recorded for 6 months after surgery. The primary outcome was the reoperation rate within 6 months. The non-inferiority margin was set at 7·5%. Key secondary outcomes that were also required to conclude non-inferiority were the proportion of participants with unfavourable functional outcomes (ie, modified Rankin Scale score of 4–6, where 0 indicates no symptoms and 6 indicates death) and mortality rate at 6 months. The primary and key secondary analyses were done in both the intention-to-treat and per-protocol populations. The trial was registered with ClinicalTrials.gov (NCT04203550) and is completed. Findings From Jan 1, 2020, to Aug 17, 2022, we assessed 1644 patients for eligibility and 589 (36%) patients were randomly assigned to a treatment group and treated (294 assigned to drainage with irrigation and 295 assigned to drainage without irrigation; 165 [28%] women and 424 [72%] men). The 6-month follow-up period extended until Feb 14, 2023. In the intention-to-treat analysis, 54 (18·3%) of 295 participants required reoperation in the group assigned to receive no irrigation versus 37 (12·6%) of 294 in the group assigned to receive irrigation (difference of 6·0 percentage points, 95% CI 0·2–11·7; p=0·30; adjusted for study site). There were no significant between-group differences in the proportion of people with modified Rankin Scale score of 4–6 (37 [13·1%] of 283 in the no-irrigation group vs 36 [12·6%] of 285 in the irrigation group; p=0·89) or mortality rate (18 [6·1%] of 295 in the no-irrigation group vs 21 [7·1%] of 294 in the irrigation group; p=0·58). The findings of the primary intention-to-treat analysis were not materially altered in the per-protocol analysis. There were no significant between-group differences in the number of adverse events, and the most frequent severe adverse events were systemic infections (26 [8·8%] of 295 participants who did not receive irrigation vs 22 [7·5%] of 294 participants who received irrigation), intracranial haemorrhage (13 [4·4%] vs seven [2·4%]), and epileptic seizures (five [1·7%] vs nine [3·1%]). Interpretation We could not conclude non-inferiority of burr-hole drainage without irrigation. The reoperation rate was 6·0 percentage points higher after burr-hole drainage without subdural irrigation than with subdural irrigation. Considering that there were no differences in functional outcome or mortality between the groups, the trial favours the use of subdural irrigation. Funding State Fund for University Level Health Research (Helsinki University Hospital), Finska Läkaresällskapet, Medicinska Understödsföreningen Liv och Hälsa, and Svenska Kulturfonden.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Leon发布了新的文献求助20
4秒前
5秒前
7秒前
Leon完成签到,获得积分10
15秒前
tingalan完成签到,获得积分0
15秒前
赵一完成签到 ,获得积分10
22秒前
34秒前
上官若男应助研友_拓跋戾采纳,获得10
39秒前
Thi发布了新的文献求助10
44秒前
无悔完成签到 ,获得积分0
50秒前
笔墨纸砚完成签到 ,获得积分10
57秒前
科研通AI2S应助科研通管家采纳,获得10
58秒前
Thi完成签到,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
吃饱再睡完成签到 ,获得积分10
1分钟前
1分钟前
量子星尘发布了新的文献求助10
1分钟前
酷酷的紫南完成签到 ,获得积分10
1分钟前
1分钟前
xue完成签到 ,获得积分10
1分钟前
冰凌心恋完成签到,获得积分10
1分钟前
2分钟前
www发布了新的文献求助10
2分钟前
hanlixuan完成签到 ,获得积分10
2分钟前
呆呆的猕猴桃完成签到 ,获得积分10
2分钟前
2分钟前
2分钟前
2分钟前
2分钟前
科研通AI6应助科研通管家采纳,获得10
2分钟前
wanci应助john2333采纳,获得10
3分钟前
奋斗的小研完成签到,获得积分10
3分钟前
3分钟前
Jin完成签到,获得积分10
3分钟前
jin完成签到,获得积分10
3分钟前
3分钟前
aming发布了新的文献求助10
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Clinical Microbiology Procedures Handbook, Multi-Volume, 5th Edition 2000
The Cambridge History of China: Volume 4, Sui and T'ang China, 589–906 AD, Part Two 1000
The Composition and Relative Chronology of Dynasties 16 and 17 in Egypt 1000
Russian Foreign Policy: Change and Continuity 800
Real World Research, 5th Edition 800
Qualitative Data Analysis with NVivo By Jenine Beekhuyzen, Pat Bazeley · 2024 800
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5715179
求助须知:如何正确求助?哪些是违规求助? 5231114
关于积分的说明 15274068
捐赠科研通 4866203
什么是DOI,文献DOI怎么找? 2612756
邀请新用户注册赠送积分活动 1562941
关于科研通互助平台的介绍 1520304